|
|
||||||||
Original Research Communication |
1 From INSERM U316, Laboratoire de Biophysique Médicale et Pharmaceutique, Université François Rabelais, Tours, France (LZ, SC, DG, and SC); the INRA, Laboratoire de Nutrition et Sécurité Alimentaire, Jouy-en-Josas, France (SV and GD); and the Centre d'Etudes du Bouchet, Vert-le-Petit, France (PB and SD).
Background: Several findings in humans support the hypothesis of links between n-3 polyunsaturated fatty acid (PUFA) status and psychiatric diseases.
Objective: The involvement of PUFAs in central nervous system function can be assessed with the use of dietary manipulation in animal models. We studied the effects of chronic dietary n-3 PUFA deficiency on mesocorticolimbic dopamine neurotransmission in rats.
Design: Using dual-probe microdialysis, we analyzed dopamine release under amphetamine stimulation simultaneously in the frontal cortex and the nucleus accumbens. The messenger RNA (mRNA) expression of vesicular monoamine transporter2 and dopamine D2 receptor was studied with the use of in situ hybridization. The protein expression of the synthesis-limiting enzyme tyrosine 3-monooxygenase (tyrosine 3-hydroxylase) was studied with the use of immunocytochemistry.
Results: Dopamine release was significantly lower in both cerebral areas in n-3 PUFAdeficient rats than in control rats, but this effect was abolished in the frontal cortex and reversed in the nucleus accumbens by reserpine pretreatment, which depletes the dopamine vesicular storage pool. The mRNA expression of vesicular monoamine transporter2 was lower in both cerebral areas in n-3 PUFAdeficient rats than in control rats, whereas the mRNA expression of D2 receptor was lower in the frontal cortex and higher in the nucleus accumbens in n-3 PUFAdeficient rats than in control rats. Finally, tyrosine 3-monooxygenase immunoreactivity was higher in the ventral tegmental area in n-3 PUFAdeficient rats than in control rats.
Conclusions: Our results suggest that the mesolimbic dopamine pathway is more active whereas the mesocortical pathway is less active in n-3 PUFAdeficient rats than in control rats. This provides new neurochemical evidence supporting the effects of n-3 PUFA deficiency on behavior.
Key Words: Dopamine mesocorticolimbic pathway frontal cortex microdialysis n-3 polyunsaturated fatty acids nucleus accumbens rats
This article has been cited by other articles:
![]() |
S. E Carlson Early determinants of development: a lipid perspective Am. J. Clinical Nutrition, May 1, 2009; 89(5): 1523S - 1529S. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E Carlson Docosahexaenoic acid supplementation in pregnancy and lactation Am. J. Clinical Nutrition, February 1, 2009; 89(2): 678S - 684S. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Song, M. S. Manku, and D. F. Horrobin Long-Chain Polyunsaturated Fatty Acids Modulate Interleukin-1{beta}-Induced Changes in Behavior, Monoaminergic Neurotransmitters, and Brain Inflammation in Rats J. Nutr., May 1, 2008; 138(5): 954 - 963. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Vancassel, S. Leman, L. Hanonick, S. Denis, J. Roger, M. Nollet, S. Bodard, I. Kousignian, C. Belzung, and S. Chalon n-3 Polyunsaturated fatty acid supplementation reverses stress-induced modifications on brain monoamine levels in mice J. Lipid Res., February 1, 2008; 49(2): 340 - 348. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Pongrac, P. J. Slack, and S. M. Innis Dietary Polyunsaturated Fat that Is Low in (n-3) and High in (n-6) Fatty Acids Alters the SNARE Protein Complex and Nitrosylation in Rat Hippocampus J. Nutr., August 1, 2007; 137(8): 1852 - 1856. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Coti Bertrand, J. R. O'Kusky, and S. M. Innis Maternal Dietary (n-3) Fatty Acid Deficiency Alters Neurogenesis in the Embryonic Rat Brain J. Nutr., June 1, 2006; 136(6): 1570 - 1575. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. DeMar Jr., K. Ma, J. M. Bell, M. Igarashi, D. Greenstein, and S. I. Rapoport One generation of n-3 polyunsaturated fatty acid deprivation increases depression and aggression test scores in rats J. Lipid Res., January 1, 2006; 47(1): 172 - 180. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Pifferi, F. Roux, B. Langelier, J.-M. Alessandri, S. Vancassel, M. Jouin, M. Lavialle, and P. Guesnet (n-3) Polyunsaturated Fatty Acid Deficiency Reduces the Expression of Both Isoforms of the Brain Glucose Transporter GLUT1 in Rats J. Nutr., September 1, 2005; 135(9): 2241 - 2246. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C McCann and B. N Ames Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals Am. J. Clinical Nutrition, August 1, 2005; 82(2): 281 - 295. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-F. Ng and S. M. Innis Behavioral Responses Are Altered in Piglets with Decreased Frontal Cortex Docosahexaenoic Acid J. Nutr., October 1, 2003; 133(10): 3222 - 3227. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Aid, S. Vancassel, C. Poumes-Ballihaut, S. Chalon, P. Guesnet, and M. Lavialle Effect of a diet-induced n-3 PUFA depletion on cholinergic parameters in the rat hippocampus J. Lipid Res., August 1, 2003; 44(8): 1545 - 1551. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |